Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001331831 | SCV001523959 | uncertain significance | Intellectual disability, autosomal recessive 58 | 2020-01-14 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ce |
RCV003992493 | SCV004810943 | uncertain significance | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | ELP2: PM2, PM3:Supporting |
Breakthrough Genomics, |
RCV003992493 | SCV005193303 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Wainwright Lab, |
RCV001310084 | SCV001482303 | likely pathogenic | Intellectual disability, profound | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004531093 | SCV004751277 | likely benign | ELP2-related disorder | 2019-06-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |